About Cancer Research UK
We are the world’s leading independent charity dedicated to cancer research. We fund scientific research to help prevent, diagnose and treat cancer.
We are the only charity fighting over 200 cancer types and we receive no government funding for our life saving research. Together with our partners and supporters, our vision is to bring forward the day when all cancers are cured.
We develop policy
Our policy development team develops evidence-based policy to inform Government decisions related to cancer and research.
We beat cancer
We fund scientists, doctors and nurses to help beat cancer sooner. We also provide cancer information to the public.
We raise money
Every step we make towards beating cancer relies on every pound donated.
We are the largest independent funder of cancer research in Europe and the world’s leading charity dedicated to cancer research, supporting research across all cancer types. We are committed to funding high-calibre, innovative research that we believe has the potential to provide the greatest benefit to the public and cancer patients.
We support researchers at all career levels and fund all stages of the research pipeline. Our broad portfolio spans basic, translational and clinical research through response mode funding, infrastructure in our Cancer Research UK Centres and through our five core-funded institutes.
Our five-year Research Strategy, launched in 2014, outlines how we will achieve our ambitions through a substantial increase in research in priority areas.
Grand Challenge is the cornerstone of our research startegy to accelerate progress towards 3 in 4 people suriving cancer in the UK by 2034. Unique in its scale and ambition - Grand Challenge seeks to tackle some of the toughest problems through international, mutldisciplinary team research on a scale not before undertaken in cancer.
Initially Cancer Research UK committed £100m over five years, one £20m grant a year to Grand Challenge. Thanks to new partnerships and interest from international philanthropists, in our first round we were able to triple our investment and fund four exceptional, international teams.